|
시장보고서
상품코드
1890975
독감 예방 주사 시장 : 백신 유형별, 가수별, 투여 경로별, 연령층별, 기술 플랫폼별, 유통 채널별, 적응증별, 주식 유형별, 지역별Injection Flu Shot Market, By Vaccine Type, By Valency, By Route of Administration, By Age Group, By Technology Platform, By Distribution Channel, By Indication, By Strain Type, By Geography |
||||||
독감 예방 주사 시장은 2025년에 91억 2,000만 달러로 추정되며, 2032년까지 150억 3,000만 달러에 달할 것으로 예측됩니다. 2025-2032년까지 CAGR 7.4%로 성장할 것으로 전망됩니다.
| 보고서 내용 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2024년 | 2025년 시장 규모: | 91억 2,000만 달러 |
| 과거 데이터 대상 기간: | 2020-2024년 | 예측 기간: | 2025-2032년 |
| 예측 기간 2025-2032년: | 7.40% | 2032년 예측치: | 150억 3,000만 달러 |
세계 독감 예방 주사 시장은 근육 주사로 투여되는 독감 백신의 개발, 제조 및 유통을 포함하여 세계 예방접종 환경에서 중요한 부문입니다. 이 백신은 계절성 독감에 대한 주요 예방책으로 작용합니다. 계절성 독감은 매년 전 세계 수백만 명의 사람들에게 영향을 미치며, 공중 보건과 경제에 심각한 부담을 주고 있습니다. 독감 예방 주사 시장에는 3가 및 4가 불활성화 독감 백신, 약독화 생백신, 재조합 독감 백신 등 여러 독감 바이러스 균주에 대한 방어력을 제공하도록 설계된 다양한 백신 제제가 포함되어 있습니다.
시장 역학은 계절적 수요 패턴, 정부의 예방접종 정책, 의료 인프라 구축, 진화하는 백신 기술 등의 요인에 의해 영향을 받습니다. 주요 제약사 및 생명공학 기업들은 백신의 효능 향상, 부작용 감소, 제조 공정 개선을 위해 연구개발에 지속적으로 투자하고 있습니다. 시장은 병원, 클리닉, 약국, 집단 예방접종센터 등 다양한 유통 채널을 아우르며, 소아부터 노인까지 다양한 연령층을 대상으로 하고 있습니다. 예방의학에 대한 인식이 높아지고 백신 접종 프로그램의 경제적 이점이 인식되면서 기술 발전과 선진국 및 신흥국 시장에서의 접근성 확대에 힘입어 세계 독감 예방 주사 시장은 계속 진화하고 있습니다.
시장 역학
세계 독감 예방 주사 시장은 여러 주요 촉진요인에 의해 성장 궤도를 가속화하고 있습니다. 특히 전염병 및 계절성 독감 유행에 대응하기 위해 백신 접종 프로그램에 대한 정부의 노력과 자금 지원 증가가 주요 성장의 촉매제가 되고 있습니다. 소비자의 의료에 대한 인식이 높아진 데다 독감 합병증 위험이 높은 고령 인구의 증가가 시장 수요를 크게 견인하고 있습니다. 세포배양 백신, 재조합 백신 등의 제조 기술을 포함한 백신 개발의 발전은 백신의 효능과 안전성을 향상시키고, 더 많은 환자들의 수용을 촉진하고 있습니다. 신흥국의 의료 인프라 확충과 콜드체인 물류 개선은 백신의 유통 및 접근성 향상에 기여하고 있습니다.
그러나 시장에는 눈에 띄는 제약도 존재합니다. 특정 계층의 백신 접종에 대한 주저, 부작용에 대한 우려, 제품 승인 및 시장 진입을 지연시킬 수 있는 규제상의 복잡성 등이 있습니다. 계절적 수요 변동은 제조업체에게 공급망 문제와 재고 관리 문제를 야기합니다. 특히 범용 독감백신 개발의 높은 연구개발 비용은 시장 관계자들에게 재정적 제약이 될 수 있습니다. 또한, 비강 스프레이 백신과 같은 대체 접종 채널과의 경쟁으로 인해 주사제 기반 제품의 시장 점유율이 제한될 수 있습니다. 이러한 도전에도 불구하고, 미접종 인구가 많은 개발도상국의 미개발 시장, 장기적인 보호를 제공할 수 있는 범용 독감 백신의 개발, 백신 접종 추적 및 환자 참여를 개선하기 위한 디지털 헬스 기술의 통합으로 인해 큰 기회가 창출되고 있습니다.
본 조사의 주요 특징
- 세계의 독감 예방 주사 시장에 대해 조사분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 동안의 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 시장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 시장 진입업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 독감 예방 주사 시장의 주요 기업을 프로파일링합니다. 회사 개요,제품 포트폴리오,주요 하이라이트,재무 실적,전략
- 이 보고서는 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 독감 예방 주사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 독감 예방 주사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것으로 보입니다.
목차
제1장 조사 목적과 가정
- 조사 목적
- 가정
- 약어
제2장 시장 범위
- 보고서 개요
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 규제 환경
- 제품 발매·승인
- PEST 분석
- Porters 분석
- 인수합병 동향
- 산업 동향
제4장 세계의 독감 예방 주사 시장 : 백신 유형별, 2020-2032년
- 불활화
- 약독화 생백신
제5장 세계의 독감 예방 주사 시장 : 가수별, 2020-2032년
- 4가
- 3가
제6장 세계의 독감 예방 주사 시장 : 투여 경로별, 2020-2032년
- 주사
- 점비 스프레이
제7장 세계의 독감 예방 주사 시장 : 연령층별, 2020-2032년
- 소아
- 성인
제8장 세계의 독감 예방 주사 시장 : 기술 플랫폼별, 2020-2032년
- 계란 유래
- 세포배양 기반
- 재조합
- mRNA 기반
제9장 세계의 독감 예방 주사 시장 : 유통 채널별, 2020-2032년
- 병원과 소매 약국
- 정부·기관용 공급업체
- 기타(예 : NGO, 국제 기관)
제10장 세계의 독감 예방 주사 시장 : 적응증별, 2020-2032년
- 계절성
- 팬데믹
제11장 세계의 독감 예방 주사 시장 : 주 유형별, 2020-2032년
- A(H1N1)
- A(H3N2)
- B(야마가타)
- B(빅토리아)
제12장 세계의 독감 예방 주사 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제13장 경쟁 구도
- Sanofi Pasteur
- GlaxoSmithKline
- CSL Seqirus
- AstraZeneca
- Pfizer
- Merck
- Moderna
- Novavax
- Bharat BIoTech
- Sinovac BIoTech
- Serum Institute of India
- Daiichi Sankyo
- Emergent BioSolutions
- BIKEN Co., Ltd.
- Abbott Laboratories
제14장 애널리스트의 추천사항
- 기회
- Coherent Opportunity Map
제15장 참고문헌과 조사 방법
- 참고문헌
- 조사 방법
- 출판사 소개
Injection Flu Shot Market is estimated to be valued at USD 9.12 Bn in 2025 and is expected to reach USD 15.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 9.12 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.40% | 2032 Value Projection: | USD 15.03 Bn |
The global injection flu shot market represents a critical segment within the global immunization landscape, encompassing the development, manufacturing, and distribution of influenza vaccines administered through intramuscular injection. These vaccines serve as the primary prophylactic measure against seasonal influenza, which affects millions of individuals worldwide annually and poses significant public health and economic burdens. The injection flu shot market includes various vaccine formulations such as trivalent and quadrivalent inactivated influenza vaccines, live attenuated influenza vaccines, and recombinant influenza vaccines, each designed to provide protection against multiple influenza virus strains.
The market dynamics are influenced by factors including seasonal demand patterns, government immunization policies, healthcare infrastructure development, and evolving vaccine technologies. Major pharmaceutical companies and biotechnology firms continuously invest in research and development to enhance vaccine efficacy, reduce adverse effects, and improve manufacturing processes. The market encompasses diverse distribution channels including hospitals, clinics, pharmacies, and mass vaccination centers, serving various demographic segments from pediatric to geriatric populations. With increasing awareness about preventive healthcare and the economic benefits of vaccination programs, the global injection flu shot market continues to evolve, driven by technological advancements and expanding accessibility across both developed and emerging markets.
Market Dynamics
The global injection flu shot market is propelled by several key drivers that collectively fuel its growth trajectory. Increasing government initiatives and funding for vaccination programs, particularly in response to pandemic preparedness and seasonal flu outbreaks, serve as primary growth catalysts. Rising healthcare awareness among consumers, coupled with growing elderly populations who are more susceptible to influenza complications, significantly drives market demand. Technological advancements in vaccine development, including cell-based and recombinant vaccine production methods, enhance vaccine efficacy and safety profiles, attracting broader patient acceptance. Expanding healthcare infrastructure in emerging economies and improved cold chain logistics facilitate better vaccine distribution and accessibility.
However, the market faces notable restraints including vaccine hesitancy among certain population segments, concerns about adverse effects, and regulatory complexities that can delay product approvals and market entry. Seasonal demand fluctuations create supply chain challenges and inventory management issues for manufacturers. High research and development costs, particularly for developing universal flu vaccines, pose financial constraints for market players. Additionally, competition from alternative vaccination routes such as nasal spray vaccines may limit market share for injection-based products. Despite these challenges, significant opportunities emerge from untapped markets in developing countries with large unvaccinated populations, development of universal flu vaccines that could provide long-term protection, and integration of digital health technologies for improved vaccination tracking and patient engagement.
Key Features of the Study
- This report provides in-depth analysis of the global injection flu shot market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global injection flu shot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Sanofi Pasteur, GlaxoSmithKline, CSL Seqirus, AstraZeneca, Pfizer, Merck, Moderna, Novavax, Bharat Biotech, Sinovac Biotech, Serum Institute of India, Daiichi Sankyo, Emergent BioSolutions, BIKEN Co., Ltd., and Abbott Laboratories.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global injection flu shot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injection flu shot market
Market Segmentation
- Vaccine Type Insights (Revenue, USD Bn, 2020 - 2032)
- Inactivated
- Live Attenuated
- Valency Insights (Revenue, USD Bn, 2020 - 2032)
- Quadrivalent
- Trivalent
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Injection
- Nasal Spray
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
- Technology Platform Insights (Revenue, USD Bn, 2020 - 2032)
- Egg-based
- Cell-based
- Recombinant
- mRNA-based
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital and Retail Pharmacies
- Government & Institutional Suppliers
- Others (e.g., NGOs, International Organizations)
- Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Seasonal
- Pandemic
- Strain Type Insights (Revenue, USD Bn, 2020 - 2032)
- A(H1N1)
- A(H3N2)
- B (Yamagata)
- B (Victoria)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Sanofi Pasteur
- GlaxoSmithKline
- CSL Seqirus
- AstraZeneca
- Pfizer
- Merck
- Moderna
- Novavax
- Bharat Biotech
- Sinovac Biotech
- Serum Institute of India
- Daiichi Sankyo
- Emergent BioSolutions
- BIKEN Co., Ltd.
- Abbott Laboratories
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Injection Flu Shot Market, By Vaccine Type
- Global Injection Flu Shot Market, By Valency
- Global Injection Flu Shot Market, By Route of Administration
- Global Injection Flu Shot Market, By Age Group
- Global Injection Flu Shot Market, By Technology Platform
- Global Injection Flu Shot Market, By Distribution Channel
- Global Injection Flu Shot Market, By Indication
- Global Injection Flu Shot Market, By Strain Type
- Global Injection Flu Shot Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Injection Flu Shot Market, By Vaccine Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Inactivated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Live Attenuated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Injection Flu Shot Market, By Valency, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Quadrivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Trivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Injection Flu Shot Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nasal Spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Injection Flu Shot Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Injection Flu Shot Market, By Technology Platform, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Egg-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cell-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Recombinant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- mRNA-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Injection Flu Shot Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital and Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Government & Institutional Suppliers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (e.g., NGOs, International Organizations)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Injection Flu Shot Market, By Indication, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Seasonal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pandemic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Injection Flu Shot Market, By Strain Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- A(H1N1)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- A(H3N2)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- B (Yamagata)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- B (Victoria)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Injection Flu Shot Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Sanofi Pasteur
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CSL Seqirus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Moderna
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novavax
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sinovac Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Serum Institute of India
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Daiichi Sankyo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Emergent BioSolutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BIKEN Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
